Petra Aigner

605 total citations
8 papers, 372 citations indexed

About

Petra Aigner is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Petra Aigner has authored 8 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 4 papers in Immunology and 3 papers in Hematology. Recurrent topics in Petra Aigner's work include Acute Myeloid Leukemia Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and interferon and immune responses (2 papers). Petra Aigner is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and interferon and immune responses (2 papers). Petra Aigner collaborates with scholars based in Austria, Hungary and Germany. Petra Aigner's co-authors include Dagmar Stoiber, Lena Müller, Andreas Teuschl, Dominik Rünzler, Karl H. Schneider, Heinz Redl, Sylvia Nürnberger, Wolfgang Holnthoner, Xavier Monforte and Richard Moriggl and has published in prestigious journals such as PLoS ONE, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Petra Aigner

8 papers receiving 372 citations

Peers

Petra Aigner

ONCOL

IMMUN

MB

SURGE

BIOMA

Justyna Czapla Poland

Benjia Liang China

Matthew Z. Madden United States

Siawosh K. Eskandari United States

Dagmar Eleveld-Trancikova Netherlands

Caroline Hammer Switzerland

Federico Villa Italy

Justyna Czapla Poland

Petra Aigner

102 ×0.7

ONCOL

109 ×0.8

IMMUN

141 ×1.4

MB

62 ×0.7

SURGE

46 ×0.6

BIOMA

Citations per year, relative to Petra Aigner Petra Aigner (= 1×) peers Justyna Czapla

Countries citing papers authored by Petra Aigner

Since Specialization

Citations

This map shows the geographic impact of Petra Aigner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Aigner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Aigner more than expected).

Fields of papers citing papers by Petra Aigner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Aigner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Aigner. The network helps show where Petra Aigner may publish in the future.

Co-authorship network of co-authors of Petra Aigner

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Aigner. A scholar is included among the top collaborators of Petra Aigner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Aigner. Petra Aigner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Aigner, Petra, et al.. (2021). Tumor suppressors in acute myeloid leukemia. Leukemia & lymphoma. 62(10). 2320–2330. 4 indexed citations

2.

Aigner, Petra, et al.. (2019). Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis. PLoS ONE. 14(8). e0220935–e0220935. 5 indexed citations

3.

Aigner, Petra, Viktor Voronin, Robert Eferl, et al.. (2019). JAK–STAT inhibition impairs K‐RAS‐driven lung adenocarcinoma progression. International Journal of Cancer. 145(12). 3376–3388. 52 indexed citations

4.

Aigner, Petra, Tatsuaki Mizutani, Thomas Eder, et al.. (2019). STAT3β is a tumor suppressor in acute myeloid leukemia. Blood Advances. 3(13). 1989–2002. 28 indexed citations

5.

Aigner, Petra, et al.. (2018). STAT3 isoforms: Alternative fates in cancer?. Cytokine. 118. 27–34. 63 indexed citations

6.

Müller, Lena, Petra Aigner, & Dagmar Stoiber. (2017). Type I Interferons and Natural Killer Cell Regulation in Cancer. Frontiers in Immunology. 8. 304–304. 125 indexed citations

7.

Bauer, Eva, Michaela Schlederer, Ruth Scheicher, et al.. (2016). Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic mice. Oncotarget. 7(11). 12191–12205. 5 indexed citations

8.

Schneider, Karl H., Petra Aigner, Wolfgang Holnthoner, et al.. (2015). Decellularized human placenta chorion matrix as a favorable source of small-diameter vascular grafts. Acta Biomaterialia. 29. 125–134. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Justyna Czapla Breakdown of academic impact, for papers by Benjia Liang Breakdown of academic impact, for papers by Matthew Z. Madden Breakdown of academic impact, for papers by Siawosh K. Eskandari Breakdown of academic impact, for papers by Dagmar Eleveld-Trancikova Breakdown of academic impact, for papers by Caroline Hammer Breakdown of academic impact, for papers by Federico Villa